ABT vs. DHR
Compare and contrast key facts about Abbott Laboratories (ABT) and Danaher Corporation (DHR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or DHR.
Correlation
The correlation between ABT and DHR is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABT vs. DHR - Performance Comparison
Loading data...
Key characteristics
ABT:
1.46
DHR:
-0.84
ABT:
2.01
DHR:
-1.03
ABT:
1.26
DHR:
0.86
ABT:
1.10
DHR:
-0.59
ABT:
6.72
DHR:
-1.38
ABT:
4.17%
DHR:
16.95%
ABT:
20.56%
DHR:
28.86%
ABT:
-45.66%
DHR:
-65.30%
ABT:
-4.54%
DHR:
-34.62%
Fundamentals
ABT:
$233.14B
DHR:
$135.78B
ABT:
$7.70
DHR:
$5.16
ABT:
17.30
DHR:
36.77
ABT:
4.17
DHR:
1.91
ABT:
5.47
DHR:
5.85
ABT:
4.78
DHR:
2.74
ABT:
$42.34B
DHR:
$23.82B
ABT:
$23.67B
DHR:
$14.23B
ABT:
$11.20B
DHR:
$7.17B
Returns By Period
In the year-to-date period, ABT achieves a 18.96% return, which is significantly higher than DHR's -17.22% return. Over the past 10 years, ABT has underperformed DHR with an annualized return of 13.14%, while DHR has yielded a comparatively higher 18.23% annualized return.
ABT
18.96%
7.52%
15.41%
29.77%
8.70%
13.14%
DHR
-17.22%
4.96%
-22.47%
-24.76%
6.21%
18.23%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABT vs. DHR — Risk-Adjusted Performance Rank
ABT
DHR
ABT vs. DHR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ABT vs. DHR - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 1.71%, more than DHR's 0.60% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 1.71% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
DHR Danaher Corporation | 0.60% | 0.47% | 0.43% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 36.46% | 0.80% | 0.47% |
Drawdowns
ABT vs. DHR - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum DHR drawdown of -65.30%. Use the drawdown chart below to compare losses from any high point for ABT and DHR. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ABT vs. DHR - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 5.15%, while Danaher Corporation (DHR) has a volatility of 11.11%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ABT vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABT vs. DHR - Profitability Comparison
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a gross profit of 3.51B and revenue of 5.74B. Therefore, the gross margin over that period was 61.2%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported an operating income of 1.27B and revenue of 5.74B, resulting in an operating margin of 22.2%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a net income of 954.00M and revenue of 5.74B, resulting in a net margin of 16.6%.